- Home
- APT vs PRLD Comparison
APT vs PRLD Comparison
Compare APT & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APT
- PRLD
- Stock Information
- Founded
- APT 1983
- PRLD 2016
- Country
- APT Canada
- PRLD United States
- Employees
- APT N/A
- PRLD N/A
- Industry
- APT
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- APT
- PRLD Health Care
- Exchange
- APT Nasdaq
- PRLD Nasdaq
- Market Cap
- APT 50.1M
- PRLD 44.0M
- IPO Year
- APT 1995
- PRLD 2020
- Fundamental
- Price
- APT $4.89
- PRLD $1.13
- Analyst Decision
- APT
- PRLD Strong Buy
- Analyst Count
- APT 0
- PRLD 3
- Target Price
- APT N/A
- PRLD $4.00
- AVG Volume (30 Days)
- APT 29.2K
- PRLD 223.3K
- Earning Date
- APT 11-05-2025
- PRLD 11-05-2025
- Dividend Yield
- APT N/A
- PRLD N/A
- EPS Growth
- APT N/A
- PRLD N/A
- EPS
- APT 0.33
- PRLD N/A
- Revenue
- APT $58,562,000.00
- PRLD $7,000,000.00
- Revenue This Year
- APT N/A
- PRLD N/A
- Revenue Next Year
- APT N/A
- PRLD N/A
- P/E Ratio
- APT $14.88
- PRLD N/A
- Revenue Growth
- APT N/A
- PRLD N/A
- 52 Week Low
- APT $4.06
- PRLD $0.61
- 52 Week High
- APT $6.20
- PRLD $5.08
- Technical
- Relative Strength Index (RSI)
- APT 59.45
- PRLD 51.85
- Support Level
- APT $4.81
- PRLD $1.10
- Resistance Level
- APT $4.99
- PRLD $1.26
- Average True Range (ATR)
- APT 0.14
- PRLD 0.13
- MACD
- APT 0.01
- PRLD -0.01
- Stochastic Oscillator
- APT 69.70
- PRLD 13.04
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.